The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein A levels with obstetrical complications in pregnancy

Journal of Thrombosis and Thrombolysis

Volumn 14, Issue 2, 2002, Pages 157-162

  Ogunyemi, Dotun ^a,b   Ku, Wayne ^c   Arkel, Yale ^c  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Lipoprotein A; Obstetrical complications; Pregnancy; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; HEPARIN; HOMOCYSTEINE; LIPOPROTEIN A; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS DEATH; GENE MUTATION; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; OLIGOHYDRAMNIOS; OUTCOMES RESEARCH; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECURRENT ABORTION; SOLUTIO PLACENTAE; STATISTICAL ANALYSIS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0037541078     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1023/A:1023241130459     Document Type: Article

References (27)

1. Blumenfeld Z, Brenner B. Thrombophilia-associated wastage. Fertil Steril 1999;72(5):765-774.
2. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999;353:1258-1265.
3. Ogunyemi D. Venous thrombosis in pregnancy. The Female Patient 2000;25(7):70-77.
4. Kuperminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
5. Ogunyemi D. The association of factor-V Leiden mutation and acquired antibodies with obstetrical complications SPO abstracts. Am J Obstet Gynecol 1999;180(1/2): 481.
6. Gharavi AE, Pierangeli SS, Levy RA, Harris EN. Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 2001;44(1)11-19.
7. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999;353:1348-1353.
8. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chemist 1997;43(9):1678-1683.
9. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
10. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
11. Den Heijerb M, Koster T, Blom, et al. Hyperhomocystenemia as a risk factor for deep venous thrombosis. N Engl Med 1996;33(4):759-762.
12. Arruda VR, Von Zuben PM, Chiaparini LC, et al. The mutation ALA677 in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Hemost 1997;77:818-821.
13. Djuvoric S, Berg K. Epidemiology of Lp(a) lipoprotein: Its role in atherosclerotic disease. Clin Genet 1997;52:281-292.
14. Harris ED. Lipoprotein (a): A predictor of atherosclerotic disease. Nutrition Reviews 1997;55(3)61-64.
15. Lubencho LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26-42 weeks. Pediatrics 1966;37:403-408.
16. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134.
17. Dilley A, Austin H, El-Jamil M, et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 2000;183(5):1271-1277.
18. Grandone E, Margaglione M, Colaizzo D, et al. Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. A J Obstet Gynecol 1998;179(5):1324-1328.
19. Gerhardt A, Scharf R, Eberhard B, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342(6):374-380.
20. Ogunyemi D, Cuellar F. Venous thromboembolism and associated thrombophilias in pregnancy. Am J Obstet Gynecol 2001;184(1):661.
21. Leeda M, Riyazi N, De Vries J, et al. Effects of folic acid and vitamin B6 supplementation on women with Hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998;179:135-139.
22. Wang J, Mimuro S, Lahoud R, et al. Elevated levels of lipoprotein (a) in women with preeclampsia. Am J Obstet Gynecol 1998;178:146-149.
23. Leerink CB, De Vries C, Van Der Klis F. Elevated levels of serum lipoprotein (a) and apolipoprotein (a) phenotype are not related to preeclampsia. Acta Obstet Gynecol Scand 1997;76:625-628.
24. Szczepanski M, Bauer A, Gardas A, Duchinski T. Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss. Int J Obstet Gynecol 1998;61:39-44.
25. Berg K, Roade B, Sande H. High Lp (a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 1994;46:52-56.
26. Raj R, Cohen H, Dave M, Regan L. Randomized trial of aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314(7076)253-257.
27. Sibai B. Thrombophilias and adverse outcomes of pregnancy - What should a clinician do? N Engl Med 1999;340(1):50-52.